Heart Rate and QT interval Variability in Multiple Sclerosis: Evidence for Decreased Sympathetic Activity
Journal Title: Journal of Neurological Sciences-Turkish - Year 2006, Vol 23, Issue 4
Abstract
Decreased beat-to-beat heart rate variability (HR) and increased beat-to-beat QT interval variability are associated with significant cardiovascular mortality. The aim of this study was to compare beat-to-beat HR and QT variability among patients with multiple sclerosis (MS) and normal controls to investigate cardiac autonomic function. We investigated spectral measures of HR and QT interval variability in 13 patients with MS and 16 normal controls during sleep. Our results showed modest but significant decreases in HR total power (TP: 0-0.5 Hz), VLF power (very low frequency power: 0-0.04 Hz) and LF power (low frequency: 0.14-0.5 Hz) in patients with MS compared to normal controls. QT interval TP, VLF, LF and HF powers were all highly significantly lower (p
Authors and Affiliations
Micahel BONNETT, Janet MULCARE, Thomas MATHEWS, Satyendra GUPTA, Nizam AHMED, Vikram YERAGANI
Multipl Skleroz'da Doğal Seyir ve Klinik Prognostik Özellikler
Amaç: Multipl skleroz(MS), farklı klinik seyir ve prognoz özellikleri gösterebilen heterojen hastalık grupları içermektedir. Hastalığın erken dönemindeki verilere dayanarak prognozu önceden belirleyebilmek MS çalışmaları...
Is Vitamin B12 Level Significant ?
Posthipoksik Aksiyon Miyoklonisi Gelişen Bir Olguda Levetirasetama Yanıt
Posthipoksik aksiyon miyoklonisi (PAM) hipoksik beyin hasarı sonrasında gelişebilir ve farmakolojik tedaviye dirençlidir. Sunulan hastada PAM sonucu oluşan çok ciddi miyoklonik sıçramalar hastayı tamamen işgöremez hale g...
Association of Inflammatory Markers with Intima-Media Thickness and Acute Ischemic Stroke
Purpose: White blood cell count (WBC), fibrinogen or C-reactive protein (CRP) were found to be increased after stroke and early onset carotid atherosclerosis was associated with increased intima-media thickness (IMT). Th...
Interferon-β Theraphy in Multiple Sclerosis Patients: is Response Age Dependent?
The onset of Multiple sclerosis (MS) is usually between 20 and 40 years and in those patients, β -interferons reduce relapse frequency in a rate of 30%. The purpose of this study was to compare the therapeutical response...